| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:2388-2394.)
© 2008 American Heart Association, Inc.
New Drugs and Technologies |
From the University of Colorado at Denver, Aurora, Colo (M.S.K., A.R.H., R.A.Q., J.D.C.); and Philips Healthcare, Bothell, Wash (O.W.).
Reprint requests to John D. Carroll, MD, University of Colorado at Denver, 12401 E 17th Ave, Room 524, Campus Mail Stop B-132, PO Box 6511, Aurora, CO 80045. E-mail John.Carroll{at}UCHSC.edu
As the appreciation of structural heart disease in children and adults has increased and as catheter-based closure procedures are now being performed in clinical practice, cardiovascular physicians have multiple compelling new reasons to better understand cardiac anatomic and spatial relationships. Current 2-dimensional imaging techniques remain limited both in their ability to represent the complex 3-dimensional relationships present in structural heart disease and in their capacity to adequately facilitate often complex corrective procedures. This review discusses the cardiovascular applications of rapid prototyping, a new technology that may not only play a significant role in the planning of catheter-based interventions but also may serve as a valuable educational tool to enhance the medical communitys understanding of the many forms of structural heart disease.
Key Words: computed tomography heart defects, congenital heart septal defects percutaneous closure rapid prototyping
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |